Recently, bacteriophages have been considered alternatives to antibacterial treatments. Infectious diseases continue to plague the world because bacteria can adapt and develop defence mechanisms against antibiotics. The growing incidence of antibiotic-resistant bacterial infections necessitated the development of new techniques for treating bacterial infections worldwide. Clinical trials have shown efficiency against antibiotic-resistant bacteria. However, scientists in future clinical trials should scrutinize phage resistance implications, assess combination strategies with antimicrobial agents and address challenges in phage therapy delivery for effective implementation.

© 2024 The Authors

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001895

2024-09-25

2024-09-26

Full text loading...

/deliver/fulltext/jmm/73/9/jmm001895.html?itemId=/content/journal/jmm/10.1099/jmm.0.001895&mimeType=html&fmt=ahah